Average spectrum of cochlear activity: a possible synchronized firing, its olivo-cochlear feedback and alterations under anesthesia.
Average spectrum of electrophysiological cochlear activity (ASECA) recorded from the cochlea or the eighth nerve is related to firing of auditory neurons and has been used recently in search of an objective measure of tinnitus both in animal models and in humans. Little is known about neuro-sensory processes underlying the spectral features of ASECA. The present study used awake and/or anesthetized animals and investigated effects of various sounds presented contralaterally and ipsilaterally. Contralateral stimulation with noise bands at frequencies above about 8 kHz and below acoustic interaural cross-talk decreased the amplitude of the 1 kHz peak of ASECA. When presented ipsilaterally noises produced either an increase or a decrease of this spectral peak when the acoustic bandwidth was respectively above or below 1.5 kHz. Pure tones when presented contralaterally had no detectable effect. When presented ipsilaterally pure tones with frequencies higher than about 4 kHz decreased the 1 kHz peak of ASECA. The detailed time course of sound-induced variations of the 1 kHz peak was measured by time averaging. The resulting response patterns resemble PST histograms of the auditory nerve. Sedation and anesthesia deepened the 500 Hz trough of ASECA and shifted it towards 400 Hz. Sedation induced a diminution and anesthesia an almost complete suppression of the decrease of the 1 kHz peak induced by contralateral noise. Overall these data indicate that ASECA would reflect synchronized firings and they provide evidence for an influence of olivo-cochlear feedback sensitive to the state of awakeness.
Cazals
Y
Y
Laboratoire d' Audiologie Expérimentale, INSERM, Université Bordeaux II, Hôpital Pellegrin, Bordeaux, France. yves.cazals@bordeaux.inserm.fr
Huang
Z W
ZW
D000161:Acoustic Stimulation; D000200:Action Potentials / Q000502:physiology; D000758:Anesthesia / Q000009:adverse effects*; D000778:Anesthetics, Dissociative / Q000008:administration & dosage / Q000633:toxicity; D000818:Animals; D001309:Auditory Threshold / Q000187:drug effects / Q000502:physiology*; D003051:Cochlea / Q000187:drug effects / Q000502:physiology*; D004195:Disease Models, Animal; D004594:Electrophysiology; D006168:Guinea Pigs; D007273:Injections, Intramuscular; D007649:Ketamine / Q000008:administration & dosage / Q000633:toxicity; D009474:Neurons / Q000166:cytology / Q000187:drug effects / Q000502:physiology; D009847:Olivary Nucleus / Q000502:physiology*; D014012:Tinnitus / Q000175:diagnosis / Q000209:etiology; D000159:Vestibulocochlear Nerve / Q000187:drug effects / Q000502:physiology*; D014991:Xylazine / Q000008:administration & dosage / Q000633:toxicity
D000778:Anesthetics, Dissociative; D014991:Xylazine; D007649:Ketamine